↓ Skip to main content

Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias

Overview of attention for article published in Frontiers in Pharmacology, June 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
Published in
Frontiers in Pharmacology, June 2022
DOI 10.3389/fphar.2022.749472
Pubmed ID
Authors

Bruno A. Lopes, Caroline Pires Poubel, Cristiane Esteves Teixeira, Aurélie Caye-Eude, Hélène Cavé, Claus Meyer, Rolf Marschalek, Mariana Boroni, Mariana Emerenciano

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 15%
Student > Ph. D. Student 4 15%
Unspecified 1 4%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Other 2 7%
Unknown 14 52%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 11%
Medicine and Dentistry 3 11%
Agricultural and Biological Sciences 2 7%
Unspecified 1 4%
Unknown 18 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2022.
All research outputs
#16,244,664
of 23,937,746 outputs
Outputs from Frontiers in Pharmacology
#7,005
of 17,788 outputs
Outputs of similar age
#251,857
of 431,185 outputs
Outputs of similar age from Frontiers in Pharmacology
#434
of 1,266 outputs
Altmetric has tracked 23,937,746 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,788 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,185 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,266 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.